Find the optimal patients for your study. Avoid the delayed discovery of underlying conditions, such as disease progression and other clinical factors that might render a patient ineligible for your trial. Develop a precise characterization of patient populations based on diagnosis (Dx), procedures (Px), prescriptions (Rx) and social determinants of health (SDOH). Iterate in real time based on varied criteria most likely to impact patient outcomes.
Bring your protocol assessment to the next level by understanding health disparities in the incidence, prevalence, mortality and burden of disease, as well as predictability of outcomes using Patient Risk Adjustment Factor (RAF) and Hierarchical Conditions Categories (HCC).
Take action based on precise identification of investigators and sites that treat the patient population for your therapeutic area. Reporting is based on Dx, Px and Rx, enabling measurement of any “variability” of provider performance including risk-adjusted cost, quality scores (efficiency and effectiveness), — all to ensure the safest possible patient recruitment process.
Accelerate the introduction of more innovative therapies to market.